ČESKÁ UROLOGIE / CZECH UROLOGY – 4 / 2016

36 / 100

282
Ces Urol 2016; 20(4): 275–284
PŘEHLEDOVÝ ČLÁNEK
LITERATURA
1. Chudobová M. Demografická situace v České republice v roce 2013, Ústav zdravotnických informací
a statistiky České republiky, 2014; číslo: 02/14. Dostupné na:
Poslední přístup: 4. 11. 2016.
2. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes
and its burden in the United States, Atlanta, 2014, GA: U.S. Department of Health and Human Services;
Dostupné na: . Po‑
slední přístup: 4. 11. 2016.
3. Xu Y, Wang L, He J, et al. 2010 China noncommunicable disease surveillance group. Prevalence and
control of diabetes in Chinese adults, JAMA. 2013; 310: 948–959.
4. Daneshgari F, Moore C. Diabetic uropathy. Semin Nephrol. 2006; 26: 182.
5. Zachoval R, Záleský M, Heráček J, et al. Neurogenní dysfunkce dolních močových cest. Neurol. praxi;
2004(4): 227.
6. Frimodt-Moller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 1980; 92: 318.
7. Yoshimura N, Chancellor M, Andersson K, Christ G. Recent advances in understanding the biology of
diabetes associated bladder complications and novel therapy. BJU int 2005; 95: 733.
8. Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes: a peripheral or central
mechanism? Neurourol Urodyn. 2007; 26: 807.
9. Hill S, Fayyad A, Jones G. Diabetes mellitus and female lower urinary tract symptoms, a review. Neu‑
rourol Urodyn. 2008; 27: 362.
10. Sasaki K, Chancellor M, Phelan M, et al. Diabetic cystopathy correlates with a long term decrease
in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168: 1259.
11. Sasaki K, Chancellor MB, Goins WF, et al. Gene therapy using replication – defective herpes simplex
virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723.
12. Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes
and stress urinary incontinence. Women Health Issue 2003; 13: 204–213.
13. Manning J, Korda A, Benness C, Solomon M. The association of obstructive defecation, lower urinary
tract dysfunction and the benign joint hypermobility syndrome, a case control study. Int. Urogynecology
J Pelvic Floor Dysfunction 2003; 14: 128–132.
14. Moore KN, Saltmarche A, Query B. Urinary incontinence. Non surgical management by family phys‑
icians. Can. Fam. Physician 2003; 49: 602–610.
15. Pinna CH, Zanardo R, Puglisi L. Prostaglandin release impairment in the bladder epithelium of the
streptozotocin induced diabetic rats. Eur Pharmacol 2000; 388: 267.
16. Geerlings SE, Meiland R, van Lith EC, et al. Adherence of type 1-fimbriated Escherichia coli to uroepi‑
thelial cells, more in diabetic women than in control subjects. Diabetes Care 2002; 25: 1405.
17. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology
of diabetes associated bladder complications and novel therapy. BJU Int. 2005; 95: 733–738.
18. Longhurst PA, Belis JA. Abnormalities of rat bladder contractility in streptozotocin induced diabetes
mellitus. J Pharmacol Exp Ther. 1986; 238: 773–777.
19. Luheshi GN, Zar MA.The effect of streptozotocin induced diabetes on cholinergic motor transmission
in the rat urinary bladder. Br J Pharmacol. 1991; 103: 1657–1662.
20. Waring JV, Wendt IR. Effects of streptozotocin induced diabetes mellitus on intracellular calcium and
contraction of longitudinal smooth muscle from rat urinary bladder. J Urol. 2000; 163: 323–330.
21. Liu G, Daneshgari F. Temporal diabetes and diuresis remodeling of the urinary bladder in the rat. Am
J Physiol Regul INtegr Comp Physiol 2006; 291: R837.